Pharming Group N.V. Investments In Associates Accounted For Using Equity Method
Pharming Group N.V. (PHAR) had Investments In Associates Accounted For Using Equity Method of $1.94 million as of 2025-12-31, per its 20-F filed 2026-04-02.
Financial Statements › Notes
ifrs-full:InvestmentsInAssociatesAccountedForUsingEquityMethod · last filed 2026-04-02
- 2020-12-31: Investments In Associates Accounted For Using Equity Method 5.80M EUR.
- 2019-12-31: Investments In Associates Accounted For Using Equity Method 5.51M EUR.
EUR
| Period end | Investments In Associates Accounted For Using Equity Method |
|---|---|
| 2020-12-31 | 5.80M EUR 20-F · filed 2021-04-07 |
| 2019-12-31 | 5.51M EUR 20-F · filed 2021-04-07 |
USD
| Period end | Investments In Associates Accounted For Using Equity Method |
|---|---|
| 2025-12-31 | $1.94M 20-F · filed 2026-04-02 |
| 2024-12-31 | $466.00K 20-F · filed 2026-04-02 |
| 2023-12-31 | $2.29M 20-F · filed 2025-04-03 |
| 2022-12-31 | $2.50M 20-F · filed 2024-04-04 |
| 2021-12-31 | $7.20M 20-F · filed 2023-04-05 |
| 2020-12-31 | $7.12M 20-F · filed 2022-04-06 |
| 2019-12-31 | $6.18M 20-F · filed 2022-04-06 |